PRAC meeting highlights 28-31 August 2023
28/08/2023
Medicines for human use
Pharmacovigilance risk assessment committee (PRAC)
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.
The current PRAC highlights from the August 2023 meeting describes measures to avoid topiramate exposure in pregnancy.